Candidate drug molecule-DNA interaction and molecular modelling of candidate drug molecule

Year 2022, Volume: 5 Issue: 6, 1547 - 1555, 25.10.2022

Ayça Karasakal Yelda Yalçın Gürkan Sülünay Parlar

https://doi.org/10.32322/jhsm.1117781

Abstract

Aim: 1,4-dihydropyridine derivative, 1-(3-phenyl propyl)-4-(2-(2-hydroxybenzylidene) hydrazone)-1,4-dihydropyridine (abbreviated as DHP) was synthesized as potential agent for Alzheimer’s disease which is a progressive neurodegenerative brain disorder affecting millions of elderly people. With this study, the electrochemical properties of DHP were investigated and its interaction with DNA was analyzed by differential pulse voltammetry (DPV) and cyclic voltammetry (CV) measurements. In addition, this study aims to determine degradation mechanism of the DHP molecule by Density-functional theory (DFT) in gas and in aqueous phase.
Material and Method: Experimental conditions such as immobilization time, the effect of the scan rate, concentration, and the effect of pH were optimized. The method was validated according to validation parameters such as range, precision, linearity, limit of detection (LOD), limit of quantitation (LOQ) and inter/intraday.
Results: Linearity study for the calibration curve of DNA and DHP with DPV was calculated in the calibration range 10-100 µg/mL. The LOD and LOQ values were calculated as 3 and 10 µg/mL and intra-day and inter-day repeatability (RSD %) were 1.85 and 3.64 µg/mL, respectively. After the DHP-DNA interaction, the oxidation currents of guanine decreased as a proof of interaction. The activation energy of the most possible path of reaction was calculated, and their thermodynamically most stable state was determined in gas phase.
Conclusion: We developed to improve a sensitive, fast and easy detection process for determination of interaction between DHP and DNA.

Keywords

DNA, candidate drug molecule, DNA-drug interaction, biosensor, DFT

Project Number

NKUBAP.00.GA.19.217

References

• Diculescu VC, Oliveria-Brett AM. In situ electrochemical evaluation of DNA in- teraction with the anticancer drug danusertib nitrenium radical product using the DNA-electrochemical biosensor. Bioelectrochemistry 2016; 107: 50–7.
• Wang J. Electrochemical biosensors: Towards point-of-care cancer diagnostics. Biosensors and Bioelectronics 2006; 21 :1887-92.
• Palecek E. Oscillographic polarography of highly polymerized deoxyribonucleic acid. Nature 1960; 188: 656-7.
• Erdem A, Ozsoz M. Electrochemical DNA biosensors based on DNA-drug interactions. Electroanalysis 2002; 14: 965-74.
• Rauf S, Gooding JJ, Akhtar K, et al. Electrochemical approach of anticancer drugs-DNA interaction. J Pharm Biomed Anal 2005; 37: 205-17.
• Egli M, Flavell A, Pyle AM, et al. Nucleic acids in chemistry and biology. 3th ed. Cambridge- UK: The Royal Society of Chemistry; 2006.
• Yang M, McGovern ME, Thompson M. Genosensor technology and the detection of interfacial nucleic acid chemistry. Anal Chim Acta 1997; 346: 259-75.
• Morales KD, Alarcon-Angeles G, Merkoci A. Nanomaterial-based sensors for the study of DNA interaction with drugs. Electroanalysis 2019; 31: 1845-67.
• Zheng Y, Yang C, Pu W, Zhang J. Carbon nanotube-based DNA biosensor for monitoring phenolic pollutants. Microchim Acta 2009; 166: 21–6.
• Wang J, Ozsoz M, Cai XH, et al. Interactions of antitumor drug daunomycin with DNA in solution and at the surface, Bioelectrochem Bioenerg 1998; 45: 33–40.
• Dogan-Topal B, Ozkan SA. A novel sensitive electrochemical DNA biosensor for assaying of anticancer drug leuprolide and its adsorptive stripping voltammetric determination. Talanta 2011; 83: 780-8.
• Prinz M, Parlar S, Bayraktar G, et al. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier. Euro J Pharm Sci 2013; 49, 603-13.
• Sameem B, Saeedi M, Mahdavi M, Shafiee A. A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease. Euro J Med Chem 2017; 128: 332-45
• Jalili-Baleh L, Nadri H, Moradi A, et al. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. Eur J Med Chem 2017; 139: 280-9.
• Reddy MVK, Rao KY, Anusha G, et al. In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives. Environ Res 2021; 199: 111320.
• Bodor N, Buchwald P, Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease. Drug Discov Today 2002; 7: 766-74.
• Alptuzun V, Parlar S, Tasli H, Erciyas E. Synthesis and antimicrobial activity of some pyridinium salts.molecules. 2009; 14: 5203-15.
• Chang Y, Jin L, Duan JJ, Zhang Q, Wang J, Lu Y. New conjugated poly(pyridinium salt) derivative: AIE characteristics, the interaction with DNA and selective fluorescence enhancement induced by DNA. RSC Advances 2015; 125: 103358-64.
• Xie BP, Qiu GH, Hu PP, et al. Simultaneous detection of Dengue and Zika virus RNA sequences with a three-dimensional Cu-based zwitterionic metal-organic framework, comparison of single and synchronous fluorescence analysis. Sensors and Actuators B: Chemical 2018; 254: 1133-40.
• Sun JF, Lu Y, Wang L, et al. Fluorescence turn-on detection of DNA based on the aggregation-induced emission of conjugated poly(pyridinium salt)s. Polymer Chem 2013; 14: 4045-51.
• Ţintaş ML, Azzouz R, Peauger L, et al. Access to highly enantioenriched donepezil-like 1,4- dihydropyridines as promising anti-Alzheimer prodrug candidates via enantioselective Tsuji allylation and organocatalytic aza-ene-type domino reactions. J Org Chem 2018; 83: 10231-40.
• Babu MN, Elumalai K, Srinivasan S, et al. Synthesis and anticholinesterase activity of a novel series of acetazolamide condensed 1,4-dihydropyridines. Carbon Resour Convers. 2019; 2: 191-7.
• Hatipoglu A, Vione D, Yalcin Y, Minero C, Cinar Z. Photo-oxidative degradation of toluene in aqueous media by hydroxyl radicals. J Photochem Photobiol A: Chem 2010; 215: 59-68.
• Atkins PW. Physical Chemistry. 6th ed. New York: Oxford University Press; 1998.
• Mierzejewska KK, Trylska J, Sadlej J. Quantum mechanical studies of lincosamides. J Mol Model 2012; 18: 2727-40.
• Gaussian 09. Revision B.04. Gaussian, Inc. Pittsburgh-PA; 2009.
• Little TA. Method validation essentials, limit of blank, limit of detection, and limit of quantitation. Biopharm Int 2015; 28: 48-51.
• Palecek E. Adsorptive transfer stripping voltammetry: effect of electrode potential on the structure of DNA adsorbed at the mercury surface. Bioelectrochem Bioenerg 1992; 28: 71–83.
• Kilic T, Topkaya SN, Ozkan Ariksoysal D, et al. Electrochemical based detection of microRNA, mir21 in breast cancer cells. Biosensors and Bioelectron 2012; 1: 195-201.
• Topkaya SN, Karasakal A, Cetin AE, Parlar S, Alptuzun V. Electrochemical characteristics of a novel pyridinium salt as a candidate drug molecule and its interaction with DNA. Electroanalysis 2020; 32: 1780-87.
• Karasakal A, Parlar S, Alptuzun V, Cetin AE, Topkaya SN. A novel molecule: 1-(2,6 dichlorobenzyl)-4-(2-(2-4-hydroxybenzylidene)hydrazinyl) pyridinium chloride and its interaction with DNA. Electroanalysis 2021; 33: 1819–25.
• Aftab S, Kurbanoglu S, Ozcelikay G, et al. Carbon quantum dots co-catalyzed with multiwalled carbon nanotubes and silver nanoparticles modified nanosensor for the electrochemical assay of anti-HIV drug Rilpivirine. Sensor Actuat B-Chem 2019; 285: 571-83.
• Marin D, Perez P, Teijeiro C, Palecek E. Voltammetric determination of mitomycin C in the presence of other anti-cancer drugs and in urine. Analytica Chimica Acta 1998; 358: 45-50.
• Teijeiro C, Red E, Marin D. Electrochemical analysis of anthramycin: hydrolysis, DNA‐interactions and quantitative determination. Electroanalysis 2000; 12: 963-8.
• Wang J, Rivas G, Cai X, et al. Accumulation and trace measurements of phenothiazine drugs at DNA-modified electrodes. Anal Chim Acta 1996; 332: 139-44.